Insys Therapeutics
| Use attributes for filter ! | |
| Stock price | INSYQ |
|---|---|
| Disclaimer | |
| Ceo | Saeed Motahari |
| Headquarters | Phoenix |
| Arizona | |
| United States | |
| Founders | John Kapoor |
| Revenue | 146. 6 million USD (2017) |
| Founded | 1990 |
| Number of employe | 343 |
| Date of Reg. | |
| Date of Upd. | |
| ID | 966750 |
About Insys Therapeutics
Founded in 1990, Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona. Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve peaks of pain in cancer patients.